Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 936-023-6 | CAS number: 950782-86-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- N-[(1R,2S)-2,6-dimethyl-2,3-dihydro-1H-inden-1-yl]-6-[(1R)-1-fluoroethyl]-1,3,5-triazine-2,4-diamine
- EC Number:
- 619-749-5
- Cas Number:
- 730979-19-8
- Molecular formula:
- C16H20FN5
- IUPAC Name:
- N-[(1R,2S)-2,6-dimethyl-2,3-dihydro-1H-inden-1-yl]-6-[(1R)-1-fluoroethyl]-1,3,5-triazine-2,4-diamine
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: R. Janvier, Le Genest St Isle, France
- Age at study initiation: at least 8 weeks
- Weight at study initiation: 20.3-25.3 g
- Housing: individually in suspended stainless steel, wire-mesh cages in a room within a barrier maintained unit with restricted entry
- Diet: Certified rodent pellet diet: AO4C-10, S.A.F.E. (Scientific Animal Food and Engineering, Route de Saint Bris, Augy, France), ad libitum
- Water: filtered and softened tap water from municipal water supply, ad libitum
- Acclimation period: at least 5 days before beginning of the study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 40-70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Concentration:
- 0, 10, 25, 50, 100% w/v in DMF
- No. of animals per dose:
- 5
- Details on study design:
- - Compound solubility: The vehicle Dimethylformamide (DMF) was selected to ensure maximum solubility of the test substance. A homogenous solution was obtained for test and control substances
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Measurement of tritiated thymidine incorporation into proliferating lymph node cells
- Criteria used to consider a positive response: A test substance is regarded as a skin sensitiser if one concentration of the test substance results in an increase of ³H-TdR incorporation of three-fold or greater, when compared to control values in the absence of skin irritation and if there is a dose-related response. The concentration of test material causing a three fold increase (i.e., an SI of 3) is known as the EC3.
TREATMENT PREPARATION AND ADMINISTRATION:
Dosing formulations were prepared by dissolving the test substance in DMF to produce the required dosing concentration (w/v). Each mouse was topically dosed once daily with 25 μL of the formulation using an Eppendorf pipette, to the dorsal surface of each ear. Mice were dosed on Days 0, 1 and 2. There was no run off of the formulation during the application.
The site of application was examined for signs of local irritation. The animals were checked for mortality and clinical signs at least once a day during the study. Individual animal body weights were measured at the start of the test and at the scheduled kill of the animals.
On Day 5, animals were moved to a radio-active suite. Each mouse was placed individually in a retention box, intravenously injected via the tail vein with 250 μL of sodium chloride (0.9%) containing 20 μCi of ³H methyl thymidine and placed in a plastic cage for 5 hours. Five hours after intravenous injection, the mice were sacrificed and the two auricular lymph nodes were removed from each mouse. The nodes from each mouse were placed in an individual tube containing physiological saline and were disaggregated by crushing with a plastic piston. A single cell suspension was obtained, free of connective tissue.
Cell suspensions were washed with 5 mL of 0.9% physiological saline, centrifuged for 20 minutes at 1800 rpm and the pellets obtained were resuspended in 2 mL of 5% trichloroacetic acid (TCA) and stored overnight at approximately +4 °C. After a final centrifugation, the pellets were resuspended in 1 mL of saline, mixed and then placed for 25 mins in an Ultrasonic Bath to ensure a thoroughly dispersed suspension. Once prepared suspensions were added to numbered scintillation pots containing 10 mL of scintillation fluid and assayed in a beta-counter. The results were expressed as disintegrations per minute (DPM) per node. Stimulation Indices (SI) were calculated according to the following formula:
SI = DPM of treated group / DPM of control group
In addition, a stimulation index (SI) was calculated using the absolute DPM value for each mouse as the numerator and the mean DPM value for the vehicle control mice as the denominator. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The results indicate that the mean values are an appropriate parameter for evaluating effects of treatment. Statistical analysis was not considered necessary.
Results and discussion
- Positive control results:
- In the positive control group given 25% alpha-Hexylcinnamaldehyde, an SI value >3 was noted (SI = 3.86). The results from the concurrent positive control substance demonstrate the validity of this assay with a positive response to treatment with alpha-Hexylcinnamaldehyde.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 1.05
- Test group / Remarks:
- 10% test substance
- Parameter:
- SI
- Value:
- 1.17
- Test group / Remarks:
- 25% test substance
- Parameter:
- SI
- Value:
- 1.16
- Test group / Remarks:
- 50% test substance
- Parameter:
- SI
- Value:
- 1.44
- Test group / Remarks:
- 100% test substance
- Parameter:
- SI
- Value:
- 3.86
- Test group / Remarks:
- 25% alpha-hexylcinnamaldehyde (positive control)
- Cellular proliferation data / Observations:
- Mean DPM per group:
control: 919.66
10%: 961.69
25%: 1076.42
50%: 1066.81
100%: 1321.87
25% HCA: 3547.80
Any other information on results incl. tables
The test substance was found to be a non-sensitising compound in the Local Lymph Node Assay.
According to the criteria of Directive 67/548/EEC and Regulation (EC) No 1272/2008 the test substance does not have to be classified as sensitising to the skin.
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.